Qiang Chen
Investitore di Private Equity presso Heda Ventures
Profilo
Qiang Chen is currently a Venture Partner at Heda Ventures.
Previously, in 2021-2022, he was the CMC Head, GM, and Co-CEO at Shanghai Genechem Co., Ltd.
Dr. Chen holds a doctorate degree from New Mexico State University and an undergraduate degree from Xiamen University.
Posizioni attive di Qiang Chen
| Società | Posizione | Inizio |
|---|---|---|
Heda Ventures
 Heda Ventures Investment ManagersFinance Heda Ventures (Heda Ventures) is a venture capital firm founded in 2016. The firm is headquartered in Sunnyvale, California. | Investitore di Private Equity | - |
Precedenti posizioni note di Qiang Chen
| Società | Posizione | Fine |
|---|---|---|
Shanghai Genechem Co., Ltd.
 Shanghai Genechem Co., Ltd. BiotechnologyHealth Technology Shanghai Genechem Co., Ltd. engages in the research and development of gene therapy, cell therapy, and new gene targeting of antibody drugs. It also provides gene targeting verification, new drug development, and medical test services. The company was founded by Yue Qiong Cao on August 23, 2002 and is headquartered in Shanghai, China. | Amministratore Delegato | 01/08/2022 |
Formazione di Qiang Chen
| Xiamen University | Undergraduate Degree |
| New Mexico State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Heda Ventures
Heda Ventures Investment ManagersFinance Heda Ventures (Heda Ventures) is a venture capital firm founded in 2016. The firm is headquartered in Sunnyvale, California. | Finance |
Shanghai Genechem Co., Ltd.
Shanghai Genechem Co., Ltd. BiotechnologyHealth Technology Shanghai Genechem Co., Ltd. engages in the research and development of gene therapy, cell therapy, and new gene targeting of antibody drugs. It also provides gene targeting verification, new drug development, and medical test services. The company was founded by Yue Qiong Cao on August 23, 2002 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Qiang Chen
